Fulltext

Regulation of human cathepsin B by alternative mRNA splicing: homeostasis, fatal errors and cell death

Baici, Antonio ; Müntener, Kathrin ; Willimann, Anna ; Zwicky, Roman

In: Biological Chemistry, 2006, vol. 387, no. 8, p. 1017-1021

Ajouter à la liste personnelle
    Titre
    • Regulation of human cathepsin B by alternative mRNA splicing: homeostasis, fatal errors and cell death
    Auteur
    • Baici, Antonio. Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
    • Müntener, Kathrin. Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
    • Willimann, Anna. Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
    • Zwicky, Roman. Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Biological Chemistry, 2006, vol. 387, no. 8, p. 1017-1021. Walter de Gruyter
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:304167
    Summary
    One of the control mechanisms of cathepsin B biosynthesis and trafficking operates through alternative splicing of pre-mRNA. An mRNA lacking exon 2 is more efficiently translated than that containing all exons, and may be responsible for elevated biosynthesis and enzyme routing to the extracellular space, with critical consequences for connective tissue integrity in pathologies such as cancer and arthritis. mRNA missing exons 2 and 3 encodes a truncated procathepsin B form that is targeted to mitochondria. This enzyme variant is catalytically inactive because it cannot properly fold. However, it provokes a cascade of events, which result first in morphological changes in intracellular organelles and the nucleus, finally leading to cell death